Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Integrated Core Strategies (US) LLC's stake in Collegium Pharmaceutical, Inc. fell to 4.70% (Schedule 13G)
Event May 7, 2026 · Filed May 12, 2026
Integrated Core Strategies (US) LLC's stake in Collegium Pharmaceutical, Inc. fell to 4.70%, 1,515,406 shares, as a passive investor on May 7, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 4.70%
- Shares
- 1,515,406
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 4.70% | 1,515,406 |
| Millennium Management LLC | 4.70% | 1,519,500 |
| Millennium Group Management LLC | 4.70% | 1,519,500 |
| Israel A. Englander | 4.70% | 1,519,500 |
Source
Related
- Collegium Pharmaceutical, Inc.
- Millennium Management LLC
- Collegium Pharmaceutical, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Santini Gino · Jun 10, 2026
- Form 4 · Freund John Gordon · May 20, 2026